Chimeric Therapeutics Limited is trading at $0.07, down 7% today, following several days of incremental declines and heightened volatility typical for this micro-cap biotech.
- There are no new ASX announcements, clinical updates, or broker notes dated around June 18–19, 2026, to explicitly explain the downward move.
- The price action suggests the drop is likely a result of routine speculative trading and low-liquidity noise rather than a reaction to fresh, company-specific information.